Xinbo Zhou

645 total citations · 1 hit paper
20 papers, 477 citations indexed

About

Xinbo Zhou is a scholar working on Oncology, Radiology, Nuclear Medicine and Imaging and Molecular Biology. According to data from OpenAlex, Xinbo Zhou has authored 20 papers receiving a total of 477 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 10 papers in Radiology, Nuclear Medicine and Imaging and 4 papers in Molecular Biology. Recurrent topics in Xinbo Zhou's work include Monoclonal and Polyclonal Antibodies Research (10 papers), HER2/EGFR in Cancer Research (8 papers) and Crystallography and molecular interactions (4 papers). Xinbo Zhou is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (10 papers), HER2/EGFR in Cancer Research (8 papers) and Crystallography and molecular interactions (4 papers). Xinbo Zhou collaborates with scholars based in China, Netherlands and Czechia. Xinbo Zhou's co-authors include Shiyong Fan, Yanming Wang, Dian Xiao, Lianqi Liu, Fei Xie, Song Li, Zheng Su, Wu Zhong, Fei Xie and Song Li and has published in prestigious journals such as SHILAP Revista de lepidopterología, International Journal of Molecular Sciences and Theranostics.

In The Last Decade

Xinbo Zhou

19 papers receiving 464 citations

Hit Papers

Antibody–drug conjugates: Recent advances in linker chemi... 2021 2026 2022 2024 2021 50 100 150 200

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xinbo Zhou China 12 278 236 162 62 38 20 477
Haley D. Neff‐LaFord United States 7 315 1.1× 321 1.4× 171 1.1× 46 0.7× 33 0.9× 17 559
Ida H. van der Meulen‐Muileman Netherlands 14 110 0.4× 66 0.3× 291 1.8× 57 0.9× 20 0.5× 21 460
Jessica Iegre United Kingdom 14 167 0.6× 99 0.4× 533 3.3× 180 2.9× 47 1.2× 19 707
Chih-Hung Chuang Taiwan 13 93 0.3× 96 0.4× 253 1.6× 59 1.0× 96 2.5× 34 479
Heidi L. Perez United States 6 235 0.8× 220 0.9× 211 1.3× 88 1.4× 38 1.0× 9 449
Hennie M.M. Schlüper Netherlands 13 218 0.8× 74 0.3× 231 1.4× 58 0.9× 10 0.3× 19 466
Subhash C. Sinha United States 12 139 0.5× 283 1.2× 294 1.8× 179 2.9× 22 0.6× 14 550
Hironori Kikkawa Japan 12 127 0.5× 75 0.3× 226 1.4× 18 0.3× 37 1.0× 23 418
Stefano Tomassi Italy 16 147 0.5× 57 0.2× 497 3.1× 156 2.5× 25 0.7× 42 746

Countries citing papers authored by Xinbo Zhou

Since Specialization
Citations

This map shows the geographic impact of Xinbo Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xinbo Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xinbo Zhou more than expected).

Fields of papers citing papers by Xinbo Zhou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xinbo Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xinbo Zhou. The network helps show where Xinbo Zhou may publish in the future.

Co-authorship network of co-authors of Xinbo Zhou

This figure shows the co-authorship network connecting the top 25 collaborators of Xinbo Zhou. A scholar is included among the top collaborators of Xinbo Zhou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xinbo Zhou. Xinbo Zhou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fan, Shiyong, Qilong Li, Lianqi Liu, et al.. (2024). Novel antibody-antibiotic conjugate using KRM-1657 as payload eliminates intracellular MRSA in vitro and in vivo. Bioorganic Chemistry. 150. 107532–107532. 1 indexed citations
2.
Lin, Chaoning, et al.. (2024). On the multi‐parameters identification of concrete dams: A novel stochastic inverse approach. International Journal for Numerical and Analytical Methods in Geomechanics. 48(16). 3792–3810.
3.
Su, Zheng, Fei Xie, Xin Xu, et al.. (2022). Development of a nitroreductase-dependent theranostic payload for antibody-drug conjugate. Bioorganic Chemistry. 129. 106190–106190. 4 indexed citations
4.
Wang, Yanming, Fei Xie, Lianqi Liu, et al.. (2022). Development of applicable thiol-linked antibody–drug conjugates with improved stability and therapeutic index. Drug Delivery. 29(1). 754–766. 17 indexed citations
6.
Zhou, Xinbo, et al.. (2022). Baloxavir Marboxil Polymorphs: Investigating the Influence of Molecule Packing on the Dissolution Behavior. Crystals. 12(4). 550–550. 3 indexed citations
7.
Su, Zheng, Dian Xiao, Fei Xie, et al.. (2021). Antibody–drug conjugates: Recent advances in linker chemistry. Acta Pharmaceutica Sinica B. 11(12). 3889–3907. 221 indexed citations breakdown →
8.
Xiao, Dian, Longlong Luo, Zhihong Wang, et al.. (2021). Development of bifunctional anti-PD-L1 antibody MMAE conjugate with cytotoxicity and immunostimulation. Bioorganic Chemistry. 116. 105366–105366. 22 indexed citations
9.
Xiao, Dian, Lei Zhao, Fei Xie, et al.. (2021). A bifunctional molecule-based strategy for the development of theranostic antibody-drug conjugate. Theranostics. 11(6). 2550–2563. 19 indexed citations
10.
Liu, Lianqi, Fei Xie, Dian Xiao, et al.. (2021). Synthesis and evaluation of highly releasable and structurally stable antibody-SN-38-conjugates. Drug Delivery. 28(1). 2603–2617. 14 indexed citations
11.
Wang, Yanming, Lianqi Liu, Shiyong Fan, et al.. (2020). Antibody-Drug Conjugate Using Ionized Cys-Linker-MMAE as the Potent Payload Shows Optimal Therapeutic Safety. Cancers. 12(3). 744–744. 26 indexed citations
12.
Xiao, Dian, Fei Xie, Wei Li, et al.. (2020). Novel antibody-drug conjugate with UV-controlled cleavage mechanism for cytotoxin release. Bioorganic Chemistry. 111. 104475–104475. 20 indexed citations
13.
Wang, Yanming, Shiyong Fan, Dian Xiao, et al.. (2019). Novel Silyl Ether-Based Acid-Cleavable Antibody-MMAE Conjugates with Appropriate Stability and Efficacy. Cancers. 11(7). 957–957. 33 indexed citations
14.
Zhou, Xinbo, et al.. (2018). Anhydrates and hemihydrate of tasimelteon: Synthesis, structure, and pharmacokinetic study. Journal of Pharmaceutical and Biomedical Analysis. 151. 235–243. 4 indexed citations
15.
Ye, Jiali, et al.. (2018). Crystal Structures and Thermodynamic Properties of New Atypical Antipsychotic Cariprazine and Its Hydrochloride. Crystallography Reports. 63(6). 930–936. 2 indexed citations
16.
17.
Wang, Yanming, Shiyong Fan, Wu Zhong, Xinbo Zhou, & Song Li. (2017). Development and Properties of Valine-Alanine based Antibody-Drug Conjugates with Monomethyl Auristatin E as the Potent Payload. International Journal of Molecular Sciences. 18(9). 1860–1860. 40 indexed citations
18.
Zhou, Xinbo, et al.. (2015). Crystal structures of vortioxetine and its methanol monosolvate. SHILAP Revista de lepidopterología. 71(8). 883–885. 4 indexed citations
19.
Liu, Yanqin, et al.. (2014). New efficient imidazolium aldoxime reactivators for nerve agent-inhibited acetylcholinesterase. Bioorganic & Medicinal Chemistry Letters. 24(24). 5743–5748. 17 indexed citations
20.
Fan, Shiyong, et al.. (2008). Synthesis and evaluation of novel chloropyridazine derivatives as potent human rhinovirus (HRV) capsid-binding inhibitors. Bioorganic & Medicinal Chemistry. 17(2). 621–624. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026